The theme of this year’s Black History Month is “Dig Deeper, Look Closer, Think Bigger”. At the Society, we will be doing this by: celebrating Black contributions to pharmacology and drug…
Neurodiversity comprises a variety of learning differences including dyslexia, dyspraxia, Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD). Often these learning…
Dr. Célian Bertin is a psychiatrist who specialises in addiction and clinical pharmacology. He is involved in a pain clinic in parallel with the completion of a PhD in neuropharmacology, which…
Jonathan Brüün will be leaving his role as CEO of the British Pharmacological Society in January 2020. He will be taking up a new post as Chief Executive of the Royal College of…
eLearning resources to help you understand pharmacogenomics and its role in personalised medicine, and enhance your knowledge of drug safety and efficacy.
The Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx) has officially launched a new eLearning portal designed to accelerate the adoption of pharmacogenomics…
BJCP article: Use of nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with an 18% increased risk of atrial fibrillation – an irregular, often rapid heart rate – in a study of…
The story of Pharmacology Matters Since its launch in 2008, Pharmacology Matters has provided a platform for pharmacologists in the UK and worldwide to share their research, explore key topics…
Please note: this article discusses the use of offensive and discriminatory language. Mental health can touch people in different ways, including through personal experience or through caring for…
Reforming an experiential pharmacology curriculum for clinical pharmacists Teaching a new generation of clinical pharmacists The landscape of pharmacy education is continuously evolving to adapt to…
